Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N
TNYA.OQ - Tenaya Therapeutics Inc
Tenaya Therapeutics Inc Interim Data from the MyPEAK-1 Phase 1b/2 Trial of TN-201 for Adults with MYBPC3-Associated Hypertrophic Cardiomyopathy Call
Jun 03, 2026 / 12:00PM GMT
=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Thank you for standing by and welcome to the My Peak One interim data call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question-and-answer session. If you would like to ask a question during that time, simply press star followed by the number 1 on your telephone keypad. Thank you. I'd now like to turn the call over to Michelle Corral, Vice President of Corporate Communications and Investor Relations. You may begin.
--------------------------------------------------------------------------------
Unidentified_2 [2]
----------------------------
Trustpilot
